Coronavirus in the Bay Area: Helpful Links to Local Resources
Updated April 6, 2021
President Biden to Move COVID-19 Vaccine Eligibility Date to April 19
President Joe Biden was announcing Tuesday that he’s bumping up his deadline for states to make all adults in the U.S. eligible for coronavirus vaccines. With states gradually expanding eligibility beyond such priority groups as older people and essential, front-line workers, the president will announce that every adult will be eligible by April 19 to sign up and get in a virtual line to be vaccinated, said White House press secretary Jen Psaki.
By the numbers: On April 6, there were 1,367 newly recorded confirmed cases in California. The state now has a total of 3,583,830 positive cases. There have been a total of 20,267,689 vaccines administered.
CDC Real-World Study Confirms Protective Benefits of mRNA COVID-19 Vaccines
A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers. These groups are more likely than the general population to be exposed to the virus because of their occupations.
CDC Updates Operational Strategy for K-12 Schools to Reflect New Evidence on Physical Distance in Classrooms
The Centers for Disease Control and Prevention (CDC) is updating K–12 school guidance to reflect the latest science on physical distance between students in classrooms. CDC now recommends that, with universal masking, students should maintain a distance of at least 3 feet in classroom settings.
Fully Vaccinated People Can Gather Without Masks, CDC Says
Fully vaccinated Americans can gather with other vaccinated people indoors without wearing a mask or social distancing, according to long-awaited guidance from federal health officials.
The recommendations also say that vaccinated people can come together in the same way — in a single household — with people considered at low-risk for severe disease, such as in the case of vaccinated grandparents visiting healthy children and grandchildren.
Merck Will Help Manufacture Johnson & Johnson’s COVID-19 Vaccine
Pharmaceutical giant Merck will help manufacture Johnson & Johnson’s COVID-19 vaccine, White House Press Secretary Jen Psaki announced, calling it “an unprecedented historic step,” considering that the two companies are normally competitors.
Merck will produce the drug substance at the heart of Johnson & Johnson’s vaccine as well as work on filling vaccine vials and getting them ready for distribution.
FDA Says Single-Dose Shot From J&J Prevents Severe COVID
Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.
The long-anticipated shot could offer the nation a third vaccine option and help speed vaccinations by requiring just one dose instead of two. Food and Drug Administration scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19, and about 85% effective against the most serious illness. The agency also said J&J’s shot is safe.
Schools Plan for Potential of Remote Learning Into the Fall
Parents of schoolchildren learning from home shouldn’t necessarily count on reclaiming the dining room table any time soon. After seeing two academic years thrown off course by the pandemic, school leaders around the country are planning for the possibility of more distance learning next fall at the start of yet another school year.
“We have no illusions that COVID will be eradicated by the time the start of the school year comes up,” said William “Chip” Sudderth III, a spokesperson for Durham, North Carolina schools, whose students have been out of school buildings since March.
“Simple is Beautiful”: One-Shot Vaccine Proves Effective
The first one-shot COVID-19 vaccine provides good protection against the illness, Johnson & Johnson reported in a key study released Friday, offering the world a potentially important new tool as it races to stay ahead of the rapidly mutating virus.
The pharmaceutical giant’s preliminary findings suggest the single-dose option may not be as strong as Pfizer’s or Moderna’s two-dose formula, and was markedly weaker against a worrisome mutated version of the virus in South Africa.
California Lifts Virus Stay-at-Home Orders, Curfew Statewide
California lifted regional stay-at-home orders across the state Monday in response to improving coronavirus conditions, returning the state to a system of county-by-county restrictions, state health officials announced.
The order had been in place in the San Francisco Bay Area, San Joaquin Valley and Southern California, covering the majority of the state’s counties. The change will allow businesses such as restaurants to resume outdoor operations in many areas, though local officials could choose to continue stricter rules. The state is also lifting a 10 p.m. to 5 a.m. curfew.
Quick Treatment With Antibody-Laden Blood Cuts Risk of Severe COVID
A clinical trial in older adults with COVID-19 shows that an early dose of blood plasma from recovered people helps to prevent the progression to severe disease.
The plasma of people who have recovered from COVID-19 contains antibodies against SARS-CoV-2. But treatment with such plasma has had mixed results, and some scientists have suggested that plasma needs to be given early in the disease course to be effective. Fernando Polack at Fundación INFANT in Buenos Aires and his colleagues conducted a rigorous clinical trial to assess the effect of treatment with plasma within 72 hours of symptom onset. Participants included people over the age of 75 and those between 65 and 74 with at least one pre-existing condition such as diabetes. Read More
By the numbers: On January 11, there were 39,839 newly recorded confirmed cases in California. The state now has a total of 2,710,801 positive cases. There have been a total of 29,965 deaths in the state.
The Data on Coronavirus and Public Holidays
As worldwide coronavirus cases continue to surge, countries are grappling with how to manage big public holidays such as Christmas and Lunar New Year, which researchers are warning could become superspreader events.
“We’re already at a high level of community spread, and we’re about to see a lot of people traveling and gathering indoors,” says Julia Marcus, an infectious-disease epidemiologist at Harvard Medical School in Boston, Massachusetts. “It’s hard to see any way that this is going to go well.”
California Rolls Out New App to Alert People of Potential COVID-19 Exposure
As California’s latest coronavirus surge spreads at a record-setting pace, state officials on Monday unveiled a new cell phone app aimed at helping Californians track their exposure to the virus.
Starting Thursday, December 10, Californians will be able to opt into the new app — dubbed CA Notify — and receive notifications on their cell phones informing them if they have been in close proximity to someone who has tested positive for the virus.
California joins more than a dozen states, including New York, Michigan and Washington, to launch exposure notification apps in recent months. Read More
COVID-19 Travel Health Notice Levels and Testing for International Travelers
On November 21, CDC revised the Travel Health Notice system for COVID-19 and released new recommendations for testing before and after international air travel to help the public make informed decisions for safer, healthier, and more responsible travel during the COVID-19 pandemic.
CDC’s Travel Health Notices inform travelers and clinicians about current health issues in destinations around the world. For most diseases, the Travel Health Notices have 3 levels. This new 4-level travel health notice system is specific to COVID-19 and details the level of COVID-19 in international destinations and U.S. territories. The COVID-19 Travel Health Notices now indicate low, moderate, high, and very high levels of COVID-19 for each destination and are based primarily on incidence rate (or new case counts in destinations with populations of 200,000 or less) and trajectory of new cases (whether new cases over the past 28 days are increasing, decreasing, or stable). Read More
Pfizer Says its Coronavirus Vaccine is 90% Effective in a Large Trial
Today, Pfizer and BioNTech announced that their experimental vaccine against the novel coronavirus is more than 90 percent effective in preventing the disease COVID-19, based on initial analysis of results from their large phase III trial. The two companies also report that no serious safety concerns have arisen thus far. To create the vaccine, researchers genetically engineered SARS-CoV-2 genes, captured their blueprint, embedded that blueprint into an RNA molecule in solution and injected the solution into the bodies of trial participants. The trial’s data have not yet been submitted for peer-review publication. If the results hold up, Pfizer and BioNTech say they could manufacture large quantities of the genetically engineered vaccine quickly. Read More
New “Close Contact” Guidelines (10.21.20)
The U.S. Centers for Disease Control (CDC) this week broadened its definition of a “close contact” with an infected person, thereby expanding “the pool of people considered at risk of contracting the novel coronavirus,” writes Lena H. Sun at The Washington Post (10/21/20). To be considered a “close contact,” the 15-minute exposure time for individuals within six feet is now cumulative or total time during a 24-hour period, not sequential, consecutive time. State and county health departments use the definition for contract tracing efforts, the story states. The CDC’s change “is likely to have its biggest impact in schools, workplaces, and other group settings where people are in contact with others for long periods of time,” Sun writes.
New Reopening Guidelines (8.28.20)
On August 28th, Governor Newsom released a new reopening framework with four tiers with colors attached to them to indicate severity. Case rates and test positivity rates will be the metrics that determine movement within the tiers which run from purple (the most restrictive) to red to orange to yellow (the least restrictive). These categories replace the state watchlist that had previously dictated whether counties could reopen or would need to close.
Reopening rollback (7.13.20)
On July 13, Gov. Newsom ordered a rollback of the state’s reopening plan in an attempt to curb the recent resurgence of COVID-19. The rollback mandates closure of restaurants, wineries, movie theaters, family entertainment centers, zoos, museums and cardrooms throughout the state. Newsom ordered even more business sectors to close in counties that are on the state’s monitoring list for more than three days; these include gyms, hair salons and barbershops, nail salons, indoor malls, non-essential offices, and places of worship. To keep track of where your county stands on reopening, take a look at this interactive map.
Around the House
We just wrapped up a team meeting on Zoom. I learned that we all spent the majority of the weekend cleaning and organizing. We assume that many people in the Bay Area are doing the same. To help, we have put together some of our favorite articles on cleaning and organizing for you:
Home With the Kids
- Scholastic Learn At Home – classroommagazines.scholastic.com/support/learnathome.html
Beware of Scammers
We are hearing reports that scammers are taking advantage of the COVID-19 situation. Over the years, our research team has produced several articles on how to keep your family safe from scammers. Here are links to a few of these articles:
- UCSF – Support Your Mental Health During the COVID-19 Outbreak
- SF Chronicle: What you need to know about mental health
- National Association of School Psychologists – Talking to Children About COVID-19
Updated Information by County
Resources for California Workers and Employers
If you’re a worker or an employer whose livelihood or business has been affected by coronavirus, refer to the following resources.